Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.
By Q. Yu, I. Stamenkovic. Genes & Development, 2000
2,257 citations recorded by the source corpus.
We have uncovered a novel functional relationship between the hyaluronan receptor CD44, the matrix metalloproteinase-9 (MMP-9) and the multifunctional cytokine TGF-beta in the control of tumor-associated tissue remodeling. CD44 provides a cell surface docking receptor for proteolytically active MMP-9 and we show here that localization of MMP-9 to cell surface is required for its ability to promote tumor invasion and angiogenesis. Our observations also indicate that MMP-9, as well as MMP-2, proteolytically cleaves latent TGF-beta, providing a novel and potentially important mechanism for TGF-beta activation. In addition, we show that MMP-9 localization to the surface of normal keratinocytes is CD44 dependent and can activate latent TGF-beta. These observations suggest that coordinated CD44, MMP-9, and TGF-beta function may provide a physiological mechanism of tissue remodeling that can be adopted by malignant cells to promote tumor growth and invasion.
Subfields: Cancer Research, Immunology and Allergy, Oncology
View Paper: https://www.semanticscholar.org/paper/d76788dda4575e15b18d5a5f94022cf0ce47d17f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cancer Research
In Immunology and Allergy
In Oncology
Citations in the corpus
- Gelatinase-mediated migration and invasion of cancer cells. (2005, background): “…1994) Pro-MMP-2 yes (Crabbe et al., 1993) Pro-MMP-9 yes yes (Fridman et al., 1995; Ray et al., 2003) Pro-MMP-13 yes (Knauper et al., 1996) Pro-TGF-β1 yes yes (Yu and Stamenkovic, 2000) Pro-TNF-α yes yes (Gearing et al., 1994) Pro-urokinase yes (Prager et al., 2003) Stromal cell derived factor…”
- Making sense of latent TGFβ activation (2003, background): “A number of proteases including plasmin, MMP-2 and MMP9 have been identified in vitro as latent TGFβ activators (Sato and Rifkin, 1989; Yu and Stamenkovic, 2000).”
- Matrix Metalloproteinases: Regulators of the Tumor Microenvironment (2010, background): “MMP-9 is compartmentalized to the cell surface by docking to the surface receptor CD44 and then proteolytically activates TGF-β (Yu and Stamenkovic, 2000).”
- Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease (2012, background): “MMP2 and MMP9 have been shown to release the ECM-bound latent TGFβ, thereby inducing collagen synthesis [92].”
- Matrix Metalloproteinase 9 and Vascular Endothelial Growth Factor Are Essential for Osteoclast Recruitment into Developing Long Bones (2000, background): “That active TGF-b and VEGF are made bioavailable by MMP-9 (Bergers et al., 2000; Yu and Stamenkovic, 2000) may be particularly relevant to the recruitment process.”
- Role for Matrix Metalloproteinase 9 after Focal Cerebral Ischemia: Effects of Gene Knockout and Enzyme Inhibition with BB-94 (2000, background): “, 1995), transforming growth factor 1-13 (TGFI-B) (Yu and Stamenkovic, 2000), and pro-fibroblast growth”
- Matrix MetalloProteinases (MMPs) andTissue Inhibitors of MetalloProteinases (TIMPs): positive and negative regulators intumor cell adhesion (2010, neutral): “Fibronectin-bound latent form TGF-β is released to its active form in the presence of MMP-2 and MMP-9and this activation is CD44 dependent [87].”
- Matrix metalloproteinases. (2010, background): “MMPs may also target and activate growth factors whose precursors are anchored to the cell surface or sequestered in the peritumour extracellular matrix [134].”
- Role of tissue stroma in cancer cell invasion (2003, background): “Multiple proteinases activate the latent TGF-β complex: plasmin, cathepsin [68], human mast cell chymase, leucocyte elastase [69], or the cell surface localization of active matrix metalloproteinase (MMP)-2 or MMP-9 [70].”
- Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development (2003, background): “For example, MMP9 can activate latent TGFβ(D’Angelo et al., 2001; Yu and Stamenkovic, 2000).”
- Control of matrix metalloproteinase catalytic activity. (2007, background): “In addition to the membrane-bound MMPs, several examples of specific cell-MMP interactions have been reported, such as the binding of MMP-2 to the αvβ3 integrin (Brooks et al., 1996), MMP-1 to the α2β1 integrin (Dumin et al., 2001; Stricker et al., 2001), MMP-9 to CD44 (Yu and Stamenkovic, 2000), an”
- TGF‐β signaling and the fibrotic response (2004, background): “For example, the plasmin proteases MMP-2 and -9, which promote matrix degradation (24), activate TGF- (25, 26).”
- Interactions between Hyaluronan and Its Receptors (CD44, RHAMM) Regulate the Activities of Inflammation and Cancer (2015, background): “It can also activate latent TGFβ and promote tumor invasion and angiogenesis (166) (Figure 3A).”